BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31357131)

  • 1. Development of a Monomeric Inhibitory RNA Aptamer Specific for FGFR3 that Acts as an Activator When Dimerized.
    Kamatkar N; Levy M; Hébert JM
    Mol Ther Nucleic Acids; 2019 Sep; 17():530-539. PubMed ID: 31357131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes.
    Yan D; Chen D; Cool SM; van Wijnen AJ; Mikecz K; Murphy G; Im HJ
    Arthritis Res Ther; 2011 Aug; 13(4):R130. PubMed ID: 21835001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redesigning a Monospecific Anti-FGFR3 Antibody to Add Selectivity for FGFR2 and Expand Antitumor Activity.
    Yin Y; Djakovic S; Marsters S; Tien J; Peng J; Tremayne J; Lee G; Neve RM; Wu Y; Merchant M; Ashkenazi A; Carter PJ
    Mol Cancer Ther; 2015 Oct; 14(10):2270-8. PubMed ID: 26269606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
    Hughes SE
    Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential distribution of fibroblast growth factor receptors (FGFRs) on foveal cones: FGFR-4 is an early marker of cone photoreceptors.
    Cornish EE; Natoli RC; Hendrickson A; Provis JM
    Mol Vis; 2004 Jan; 10():1-14. PubMed ID: 14737068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dlg-1 Interacts With and Regulates the Activities of Fibroblast Growth Factor Receptors and EphA2 in the Mouse Lens.
    Lee S; Shatadal S; Griep AE
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):707-18. PubMed ID: 26906157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity.
    Vlacic G; Hoda MA; Klikovits T; Sinn K; Gschwandtner E; Mohorcic K; Schelch K; Pirker C; Peter-Vörösmarty B; Brankovic J; Dome B; Laszlo V; Cufer T; Rozman A; Klepetko W; Grasl-Kraupp B; Hegedus B; Berger W; Kern I; Grusch M
    Cells; 2019 Sep; 8(9):. PubMed ID: 31527449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARQ 087 inhibits FGFR signaling and rescues aberrant cell proliferation and differentiation in experimental models of craniosynostoses and chondrodysplasias caused by activating mutations in FGFR1, FGFR2 and FGFR3.
    Balek L; Gudernova I; Vesela I; Hampl M; Oralova V; Kunova Bosakova M; Varecha M; Nemec P; Hall T; Abbadessa G; Hatch N; Buchtova M; Krejci P
    Bone; 2017 Dec; 105():57-66. PubMed ID: 28826843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
    Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
    J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1.
    Chellaiah AT; McEwen DG; Werner S; Xu J; Ornitz DM
    J Biol Chem; 1994 Apr; 269(15):11620-7. PubMed ID: 7512569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential roles of fibroblast growth factor receptors (FGFR) 1, 2 and 3 in the regulation of S115 breast cancer cell growth.
    Tarkkonen KM; Nilsson EM; Kähkönen TE; Dey JH; Heikkilä JE; Tuomela JM; Liu Q; Hynes NE; Härkönen PL
    PLoS One; 2012; 7(11):e49970. PubMed ID: 23185502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of LHQ490 as a highly selective fibroblast growth factor receptor 2 (FGFR2) inhibitor.
    Li H; Ke R; Zhou Y; Chang S; Wang J; Su C; Wu P; Yang B; Wang Z; Ding K; Ma D
    Eur J Med Chem; 2024 May; 272():116473. PubMed ID: 38718625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation.
    Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Nakazawa N; Taniwaki M; Yawata Y; Ueki A
    Int J Oncol; 1999 Dec; 15(6):1205-12. PubMed ID: 10568829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of aptamer-target interactions by branched selection and high-throughput sequencing of SELEX pools.
    Dupont DM; Larsen N; Jensen JK; Andreasen PA; Kjems J
    Nucleic Acids Res; 2015 Dec; 43(21):e139. PubMed ID: 26163061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains.
    Wang Q; Green RP; Zhao G; Ornitz DM
    Development; 2001 Oct; 128(19):3867-76. PubMed ID: 11585811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primer-free aptamer selection using a random DNA library.
    Pan W; Xin P; Patrick S; Dean S; Keating C; Clawson G
    J Vis Exp; 2010 Jul; (41):. PubMed ID: 20689511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel alternatively spliced fibroblast growth factor receptor 3 isoform lacking the acid box domain is expressed during chondrogenic differentiation of ATDC5 cells.
    Shimizu A; Tada K; Shukunami C; Hiraki Y; Kurokawa T; Magane N; Kurokawa-Seo M
    J Biol Chem; 2001 Apr; 276(14):11031-40. PubMed ID: 11134040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup.
    Baldia PH; Maurer A; Heide T; Rose M; Stoehr R; Hartmann A; Williams SV; Knowles MA; Knuechel R; Gaisa NT
    Oncotarget; 2016 Nov; 7(44):71429-71439. PubMed ID: 27669755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficient screening for 8-oxoguanine DNA glycosylase binding aptamers via capillary electrophoresis].
    Han S; Zhao L; Yang G; Qu F
    Se Pu; 2021 Jul; 39(7):721-729. PubMed ID: 34227370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression.
    Ware KE; Marshall ME; Heasley LR; Marek L; Hinz TK; Hercule P; Helfrich BA; Doebele RC; Heasley LE
    PLoS One; 2010 Nov; 5(11):e14117. PubMed ID: 21152424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.